Literature DB >> 2190424

Drug-exposed neonates.

G Hoegerman1, C A Wilson, E Thurmond, S H Schnoll.   

Abstract

Drug use during pregnancy can have detrimental effects--both nonspecific and highly specific--on the perinatal outcome. Nonspecific effects include fetal growth retardation, resulting in small infants and decreased head circumference. Specific effects include facial dysmorphology and organ system anomalies such as alcohol-related birth defects. Patients abusing drugs are at an increased risk for preterm labor, thereby placing an already compromised fetus at increased risk. The number of mothers and infants being infected by the human immunodeficiency virus from sharing needles, multiple sexual contacts, and mother-to-infant transmission is increasing at an alarming rate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190424      PMCID: PMC1002411     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  40 in total

1.  AIDS and women: remaining ethical issues.

Authors:  N K Bell
Journal:  AIDS Educ Prev       Date:  1989

2.  Neurobehavioral dose-response effects of prenatal alcohol exposure in humans from infancy to adulthood.

Authors:  A P Streissguth; P D Sampson; H M Barr
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Alcohol-related birth defects: assessing the risk.

Authors:  C B Ernhart; R J Sokol; J W Ager; M Morrow-Tlucak; S Martier
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

4.  Perinatal cerebral infarction and maternal cocaine use.

Authors:  I J Chasnoff; M E Bussey; R Savich; C M Stack
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

Review 5.  Behavior and development patterns in children born to heroin-addicted and methadone-addicted mothers.

Authors:  S M Hayford; R P Epps; M Dahl-Regis
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

6.  Prenatal cocaine exposure is associated with respiratory pattern abnormalities.

Authors:  I J Chasnoff; C E Hunt; R Kletter; D Kaplan
Journal:  Am J Dis Child       Date:  1989-05

7.  Behaviour in first year after drug dependent pregnancy.

Authors:  A L van Baar; P Fleury; C A Ultee
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

8.  Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.

Authors:  I J Chasnoff; S H Schnoll; W J Burns; K Burns
Journal:  Neurobehav Toxicol Teratol       Date:  1984 Jul-Aug

Review 9.  Smoking and reproductive health.

Authors:  E Weisberg
Journal:  Clin Reprod Fertil       Date:  1985-09

10.  A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.

Authors:  S Blanche; C Rouzioux; M L Moscato; F Veber; M J Mayaux; C Jacomet; J Tricoire; A Deville; M Vial; G Firtion
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

View more
  5 in total

1.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

2.  Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System.

Authors:  E Gomez-Pomar; A Christian; L Devlin; K T Ibonia; V A Concina; H Bada; P M Westgate
Journal:  J Perinatol       Date:  2017-04-06       Impact factor: 2.521

Review 3.  Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination.

Authors:  Brandon Velasco; Esraa Mohamed; Carmen Sato-Bigbee
Journal:  Neurotoxicol Teratol       Date:  2021-06-12       Impact factor: 4.071

Review 4.  The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management.

Authors:  Enrique Gomez-Pomar; Loretta P Finnegan
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

5.  Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.

Authors:  Enrique Gomez Pomar; Loretta P Finnegan; Lori Devlin; Henrietta Bada; Vanessa A Concina; Katrina T Ibonia; Philip M Westgate
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.